FAILED
首站-论文投稿智能助手
典型文献
Call for action: Increased healthcare utilization with growing use of percutaneous cholecystectomy tube over initial cholecystectomy in cirrhotics
文献摘要:
Background: Acute calculous cholecystitis (ACC) is frequently seen in cirrhotics, with some being poor candidates for initial cholecystectomy. Instead, these patients may undergo percutaneous cholecystostomy tube (PCT) placement. We studied the healthcare utilization and predictors of cholecystectomy and PCT in patients with ACC.Methods: The National Database was queried to study all cirrhotics and non-cirrhotics with ACC between 2010–2014 who underwent initial PCT (with or without follow-up cholecystectomy) or cholecystectomy. Cirrhotic patients were divided into compensated and decompensated cirrhosis. Independent predictors and outcomes of initial PCT and failure to undergo subsequent cholecystectomy were studied. Results: Out of 919189 patients with ACC, 13283 (1.4%) had cirrhosis. Among cirrhotics, cholecystec- tomy was performed in 12790 (96.3%) and PCT in the remaining 493 (3.7%). PCT was more frequent in cirrhotics (3.7%) than in non-cirrhotics (1.4%). Multivariate analyses showed increased early readmis- sions [odds ratio (OR) = 2.12, 95% confidence interval (CI): 1.43–3.13, P < 0.001], length of stay (effect ratio = 1.39, 95% CI: 1.20–1.61, P < 0.001), calendar-year hospital cost (effect ratio = 1.34, 95% CI: 1.28–1.39, P < 0.001) and calendar-year mortality (hazard ratio = 1.89, 95% CI: 1.07–3.29, P = 0.030) in cir- rhotics undergoing initial PCT compared to cholecystectomy. Decompensated cirrhosis (OR = 2.25, 95% CI: 1.67–3.03, P < 0.001) had the highest odds of getting initial PCT. Cirrhosis, regardless of compensated (OR = 0.56, 95% CI: 0.34–0.90, P = 0.020) or decompensated (OR = 0.28, 95% CI: 0.14–0.59, P < 0.001), reduced the chances of getting a subsequent cholecystectomy. Conclusions: Cirrhotic patients undergo fewer cholecystectomy incurring initial PCT instead. Moreover, the rates of follow-up cholecystectomy are lower in cirrhotics. Increased healthcare utilization is seen with initial PCT amongst cirrhotic patients. This situation reflects suboptimal management of ACC in cirrhotics and a call for action.
文献关键词:
作者姓名:
Srikanth Vedachalam;Sajid Jalil;Somashaker G Krishna;Kyle Porter;Na Li;Sean G Kelly;Lanla Conteh;Khalid Mumtaz
作者机构:
Department of Internal Medicine,The Ohio State University Wexner Medical Center,Columbus,OH 43210,USA;Division of Gastroenterology,Hepatology and Nutrition,The Ohio State University Wexner Medical Center,Columbus,OH 43210,USA;Center for Biostatistics,Department of Biomedical Informatics,The Ohio State University Wexner Medical Center,Columbus,OH 43210,USA
引用格式:
[1]Srikanth Vedachalam;Sajid Jalil;Somashaker G Krishna;Kyle Porter;Na Li;Sean G Kelly;Lanla Conteh;Khalid Mumtaz-.Call for action: Increased healthcare utilization with growing use of percutaneous cholecystectomy tube over initial cholecystectomy in cirrhotics)[J].国际肝胆胰疾病杂志(英文版),2022(01):56-62
A类:
cirrhotics,calculous,cholecystostomy,readmis,rhotics,Decompensated
B类:
Call,action,Increased,healthcare,utilization,growing,use,percutaneous,cholecystectomy,tube,initial,Background,Acute,cholecystitis,ACC,frequently,seen,some,being,poor,candidates,Instead,these,patients,may,PCT,placement,We,studied,predictors,Methods,National,Database,was,queried,study,between,who,underwent,without,follow,up,Cirrhotic,were,divided,into,decompensated,cirrhosis,Independent,outcomes,failure,subsequent,Results,Out,had,Among,performed,remaining,more,than,Multivariate,analyses,showed,increased,early,odds,ratio,confidence,interval,length,stay,effect,calendar,year,hospital,cost,mortality,hazard,undergoing,compared,highest,getting,Cirrhosis,regardless,reduced,chances,Conclusions,fewer,incurring,instead,Moreover,rates,lower,amongst,This,situation,reflects,suboptimal,management,call
AB值:
0.421047
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Prevalence and risk factors of enteral nutrition intolerance in intensive care unit patients: a retrospective study
Yu Kunrong;Guo Na;Zhang Dingding;Xia Ying;Meng Yanling;Weng Li;Du Bin-Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;Department of Nursing, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;Department of Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail
Chen Nan;Xing Changying;Niu Jianying;Liu Bicheng;Fu Junzhou;Zhao Jiuyang;Ni Zhaohui;Wang Mei;Liu Wenhu;Zhao Jinghong;Zhong Ling;Wu Xiongfei;Li Wenge;Chen Yuqing;Shi Wei;Chen Jianghua;Yin Aiping;Fu Ping;Wang Rong;Jiang Gengru;Hou Fanfan;Ding Guohua;Chen Jing;Xu Gang;Kondo Yuichiro;Su Yuliang;Mei Changlin-Department of Nephrology, Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai 200025, China;Department of Nephrology, Jiangsu Provincial Hospital, Nanjing, Jiangsu 210036, China;Department of Nephrology, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China;Department of Nephrology, Zhongda Hospital Southeast University, Nanjing, Jiangsu 210009, China;Department of Nephrology, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180, China;Department of Nephrology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116027, China;Department of Nephrology, Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai 200001, China;Department of Nephrology, Peking University People's Hospital, Beijing 100044, China;Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Nephrology, Xinqiao Hospital of Army Medical University, Chongqing 400037, China;Department of Nephrology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China;Department of Nephrology, Southwest Hospital of Army Medical University, Chongqing 400039, China;Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China;Department of Nephrology, Peking University First Hospital, Beijing 100034, China;Department of Nephrology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong 510080, China;Department of Nephrology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China;Department of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China;Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Nephrology, Shandong Provincial Hospital, Jinan, Shandong 250021, China;Department of Nephrology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Department of Nephrology, Nanfang Hospital Southern Medical University, Guangzhou, Guangdong 510510, China;Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China;Department of Nephrology, Huashan Hospital, Fudan University, Shanghai 200040, China;Department of Nephrology, Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;R&D Planning Department, R&D Division, Kyowa Kirin Co., Ltd, Tokyo 520-5292, Japan;D&R office, Kyowa Kirin China Pharmaceutical Co., Ltd, Shanghai 201203, China;Department of Nephrology, Shanghai Changzheng Hospital, Shanghai 200003, China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。